EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients

Giada Mondanelli, Elena Orecchini, Claudia Volpi, Eleonora Panfili, Maria Laura Belladonna iD, Maria Teresa Pallotta, Simone Moretti, Roberta Galarini, Susanna Esposito, Ciriana Orabona iD

International Journal of Tryptophan Research · 2020-01 · 13

DOI: 10.1177/1178646920956646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Tryptophan Research, online erschienen am 29.09.2020. Verfasst von Giada Mondanelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Perugia, Perugia, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes (T1D) is characterized by anomalous functioning of the immuno regulatory, tryptophan-catabolic enzyme indoleamine 2,3 dioxygenase 1 (IDO1). In T1D, the levels of kynurenine—the first byproduct of tryptophan degradation via IDO1—are significantly lower than in nondiabetic controls, such that defective immune regulation by IDO1 has been recognized as potentially contributing to autoimmunity in T1D. Because tryptophan catabolism—and the production of immune regulatory catabolites—also occurs via the gut microbiota, we measured serum levels of tryptophan, and metabolites thereof, in pediatric, diabetic patients after a 3-month oral course of Lactobacillus rhamnosus GG. Daily administration of the probiotic significantly affected circulating levels of tryptophan as well as the qualitative pattern of metabolite formation in the diabetic patients, while it decreased inflammatory cytokine production by the patients. This study suggests for the first time that a probiotic treatment may affect systemic tryptophan metabolism and restrain proinflammatory profile in pediatric T1D.

Schlagwörter

Stichwörter der Autor:innen

Serum tryptophan metabolitesimmunoregulationprobioticproinflammatory cytokinestype 1 diabetes

Autor:innen und Institutionen

  • Department of Experimental Medicine, University of Perugia, Perugia, Italy.
  • Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati," Perugia, Italy.
  • Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.

ORCID-Profile: Maria Laura Belladonna, Ciriana Orabona

Zitieren

APA

Mondanelli, G., Orecchini, E., Volpi, C., Panfili, E., Belladonna, M. L., Pallotta, M. T., Moretti, S., Galarini, R., Esposito, S., & Orabona, C. (2020). Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients. International Journal of Tryptophan Research, 13. https://doi.org/10.1177/1178646920956646

Vancouver

Mondanelli G, Orecchini E, Volpi C, Panfili E, Belladonna ML, Pallotta MT, et al. Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients. International Journal of Tryptophan Research. 2020;13. doi:10.1177/1178646920956646

BibTeX
@article{Mondanelli2020,
  author = {Mondanelli, Giada and Orecchini, Elena and Volpi, Claudia and Panfili, Eleonora and Belladonna, Maria Laura and Pallotta, Maria Teresa and Moretti, Simone and Galarini, Roberta and Esposito, Susanna and Orabona, Ciriana},
  title = {Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients},
  journal = {International Journal of Tryptophan Research},
  year = {2020},
  volume = {13},
  doi = {10.1177/1178646920956646}
}
Kostenlos starten →